2021
DOI: 10.4269/ajtmh.20-1506
|View full text |Cite
|
Sign up to set email alerts
|

Who Will Pay for the COVID-19 Vaccines for Africa?

Abstract: Africa’s health systems are strained by the COVID-19 pandemic. There are global efforts toward the development and trial of COVID-19 vaccines. However, considering the challenges and economic conditions of African nations, there could be limited access and availability of the vaccines on the continent. This will be the result of high cost and technical requirements to acquire the vaccines. There are indications that possible donor funding for COVID-19 vaccines from rich countries maybe put off considering the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
26
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 26 publications
(26 citation statements)
references
References 10 publications
0
26
0
Order By: Relevance
“…It is responsible for the eradication of rinderpest and smallpox and the control of infectious diseases such as polio in many parts of the world . It is therefore clear that a safe, highly effective, and globally acceptable and equitable vaccination program, together with pre-existing precautionary measures, is essential to effectively contain the outbreak (Lucero-Prisno et al, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…It is responsible for the eradication of rinderpest and smallpox and the control of infectious diseases such as polio in many parts of the world . It is therefore clear that a safe, highly effective, and globally acceptable and equitable vaccination program, together with pre-existing precautionary measures, is essential to effectively contain the outbreak (Lucero-Prisno et al, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…This would only be achieved if there was a wide acceptance of intake of the launched vaccines among the general public to reach a broad immunological protection. (12) If there is a vaccine hesitancy, the minimal required herd immunity (55 to 82% of community) will not be achieved. Hence, some individuals will not be eligible to receive COVID-19 vaccine because of age, pregnancy, immune-compromised or any other contraindicated conditions, the refusal of vaccine intake should not exceed 10% in the community.…”
Section: Discussionmentioning
confidence: 99%
“…This is likely one of the reasons for the disappointing progress in fighting CKD. The COVID-19 vaccine being almost exclusively available in higher-income settings is also a matter of major concern [ 97 ].…”
Section: The Covid-19 Crisis: Stressing the Need To Focus On Kidney Diseasementioning
confidence: 99%